熱門資訊> 正文

Apotex为2025年IPO做准备-报告

2024-11-02 00:55

Canadian pharma Apotex has reportedly hired banks in preparation for an IPO filing in 2025.
RBC Capital Markets, Jefferies Financial Group and TD Securities have been hired as advisers, Bloomberg reported.
Apotex was bought by private equity firm SK Capital Partners in 2023. At the time, the purchase valued the company at between C$3 billion and C$4 billion (~$2.2B-~$2.9B), according to Bloomberg.

More on etc.

Westwood Holdings Group, Inc. (WHG) Q3 2024 Earnings Conference Call Transcript
Is The High VIX Just Pre-Election Jitters, Or Is It Saying Something?
Simon Property Group, Inc. (SPG) Q3 2024 Earnings Call Transcript
New York Times Q3 2024 Earnings Preview
Fox Q1 2025 Earnings Preview

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。